2022 Family Meeting
- Day One Opening Remarks – Maria Carrillo
- LEADS Study Updates – Liana Apostolova
- Learnings from Imaging, Blood, Cerebrospinal Fluid & Genetics – Gil Rabinovici
- Brain & Behavioral Changes – Brad Dickerson
- Treatment Updates & Perspectives – Liana Apostolova
- Social Workers Resources – Ashley Reiff
- Importance of Neuropathology & Brain Donation – Jessica Tranovich
- Overview of Diagnostics & Biomarkers in LEADS – Jeff Dage & David Clark
- Day One Closing Remarks – Jay Reinstein
- Day Two Opening Remarks – Liana Apostolova
- Day Two Keynote – Joe Montminy
- Communications & Considerations When Communicating with Research Participants – Katie Maslow
- Overview of Medical & Care Resources Following a Diagnosis – Angelina Polsinelli & Lindsey Wineholt
- Day Two Closing Remarks – Maria Carrillo
2021 Family Meeting
- Opening Keynote LEADS: Study goals and future directions – Liana G. Apostolova
- Understanding Brain and Behavioral Changes Related to Cognitive Impairment – Including Alzheimer’s, Frontotemporal Dementia, Primary Progressive Aphasia and More – Brad C. Dickerson
- Patient Perspective on the Importance of Receiving an Early Diagnosis – Cindy Weinstein
- Practical Considerations When Living with Early Onset Cognitive Impairment: Conversations with Attorney Pamela Greenfield – Katherine Brandt & Pamela Greenfield
- Alzheimer’s Association Panel: Identifying and accessing support groups, other resources, and getting engaged with advocacy – Robert Egge & Beth Kallmyer
- Understanding Biomarkers – Imaging, Blood, Cerebrospinal Fluid and Genetics – Gil. D. Rabinovici
- Panel Session: Aducanumab Approval and the Dementia Treatment Pipeline: Considerations for Dementia in the Younger Person
AAIC 2020 Featured Topic Sessions - Sporadic Early Onset Alzheimer's Disease in the Spotlight
- AAIC Study Design & Clinical Characteristics of the LEADS Cohort – Liana G. Apostolova
- Amyloid & Tau PETS in Sporadic Early-Onset Alzheimer’s Disease: Preliminary Results from LEADS – Gil. D. Rabinovici
- MRI Measures of Neurodegeneration in the LEADS Cohort – Brad C. Dickerson
- Examing Early-Onset & Late-Onset Alzheimer’s Disease (EOAD) to Understand the Neuropathological Substract of Typical and Atypical AD – Lea Tenenholz Grinberg
